ArticlePaclitaxel as a possible continuation maintenance therapy in advanced non-small-cell lung cancer
ArticlePaclitaxel as a possible continuation maintenance therapy in advanced non-small-cell lung cancer
ArticleSecond-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Single Institution Experience
ArticleSecond-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Single Institution Experience
ArticleTumor-derived Vascular Endothelial Growth Factor and Angiopoietin-2 in Non-small Cell Lung Cancer
ArticleTumor-derived Vascular Endothelial Growth Factor and Angiopoietin-2 in Non-small Cell Lung Cancer
ArticlePrognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer
ArticlePrognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer
ArticleINVESTIGATION OF ANTICANCER MECHANISMS OF A CHALCONE/XANTHINE HYBRID IN NON-SMALL CELL LUNG CANCER
ArticleINVESTIGATION OF ANTICANCER MECHANISMS OF A CHALCONE/XANTHINE HYBRID IN NON-SMALL CELL LUNG CANCER
ArticleTherapeutic, chemo-sensitizing, protective effects of natural products against cancerous cells: Preclinical and clinical studies
ArticleTherapeutic, chemo-sensitizing, protective effects of natural products against cancerous cells: Preclinical and clinical studies
ArticleSulforaphane Can Intensify The Antitumor Effect Of Gemcitabine By Targeting Cancer Stem Cells In Non-small Cell Lung Cancer Via Suppressing TGF-β1/TNF-α Factor
ArticleSulforaphane Can Intensify The Antitumor Effect Of Gemcitabine By Targeting Cancer Stem Cells In Non-small Cell Lung Cancer Via Suppressing TGF-β1/TNF-α Factor